Uptake and Costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013

JAMA - Journal of the American Medical Association

Volumn 312, Issue 23, 2014, Pages 2542-2550

  Bekelman, Justin E ^a,b,c   Sylwestrzak, Gosia ^d   Barron, John ^d   Liu, Jinan ^d   Epstein, Andrew J ^b,c,e   Freedman, Gary ^a   Malin, Jennifer ^f   Emanuel, Ezekiel J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HEALTHCORE INC   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Wellpoint Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HUMAN; HYPOFRACTIONATED WHOLE BREAST IRRADIATION; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; ADJUVANT RADIOTHERAPY; AGED; BREAST NEOPLASMS; ECONOMICS; HEALTH INSURANCE; MIDDLE AGED; PROTOCOL COMPLIANCE; RADIATION DOSE FRACTIONATION; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

AGED; BREAST NEOPLASMS; COHORT STUDIES; DOSE FRACTIONATION; FEMALE; GUIDELINE ADHERENCE; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84919359545     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.16616     Document Type: Article

References (28)

1. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103(2):117-128.
2. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28(21):3437-3441.
3. Darby S, McGale P, Correa C, et al; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716.
4. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362 (6):513-520.
5. Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143-1150.
6. Bentzen SM, Agrawal RK, Aird EG, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9 (4):331-341.
7. Bentzen SM, Agrawal RK, Aird EG, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618): 1098-1107.
8. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7(6):467-471.
9. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005;75(1):9-17.
10. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;81(1):59-68.
11. Haviland JS, Owen JR, Dewar JA, et al; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14 (11):1086-1094.
12. ASTRO releases list of five radiation oncology treatments to question as part of national Choosing Wisely campaign. http://www.choosingwisely.org/astro-releases-list-of-five-radiation-oncology -treatments-to-question-as-part-of-national -choosing-wisely-campaign. Accessed August 8, 2014.
13. Hoopes DJ, Kaziska D, Chapin P, et al. Patient preferences and physician practice patterns regarding breast radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(2):674-681.
14. Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307(17):1827-1837.
15. Gold HT, Do HT. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res. 2007;42(5):2056-2069.
16. Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. Amethod to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov. doi: 10.1186/1742-5573-7-1.
17. Bekelman JE, Epstein AJ, Emanuel EJ. Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. JAMA. 2013;310(14):1501-1502.
18. Dorn PL, Corbin KS, Al-Hallaq H, Hasan Y, Chmura SJ. Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients. Int J Radiat Oncol Biol Phys. 2012; 83(1):79-83.
19. Prabhakar R, Haresh KP, Julka PK, et al. A study on contralateral breast surface dose for various tangential field techniques and the impact of set-up error on this dose. Australas Phys Eng Sci Med. 2007;30(1):42-45.
20. Clark JM, Chang HY, Bolen SD, Shore AD, Goodwin SM,Weiner JP. Development of a claims-based risk score to identify obese individuals. Popul Health Manag. 2010;13(4):201-207.
21. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, BrownML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888-897.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45 (6):613-619.
23. Smith BD, Pan IW, Shih YCT, et al. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst. 2011; 103(10):798-809.
24. Area Health Resources Files (AHRF): 2012-2013. Rockville, MD: US Dept of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions.
25. Ashworth A, KongW, Whelan T, MackillopWJ. A population-based study of the fractionation of postlumpectomy breast radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86(1):51-57.
26. Harnett A. Fewer fractions of adjuvant external beam radiotherapy for early breast cancer are safe and effective and can now be the standard of care: why the UK's NICE accepts fewer fractions as the standard of care for adjuvant radiotherapy in early breast cancer. Breast. 2010;19(3):159-162.
27. Yarnold J, Bentzen SM, Coles C, Haviland J. Hypofractionated whole-breast radiotherapy for women with early breast cancer:myths and realities. Int J Radiat Oncol Biol Phys. 2011;79(1):1-9.
28. Nicholson S, PaulyMV, Polsky D, Sharda C, Szrek H, Berger ML. Measuring the effects of work loss on productivity with team production. Health Econ. 2006;15(2):111-123.